Montauk Renewables (MNTK) Q1 2026 earnings review
Top-Line Growth Masks Reversing Operating Margins
Montauk Renewables delivered a low-quality earnings beat in Q1. While revenue grew 9% YoY to $46.4 million driven by a 25.5% increase in RINs sold, underlying operational profitability is reversing. Operating income flipped to a loss of $1.6 million (vs. a $0.4 million profit a year ago). The company barely scraped together $5 thousand in net income, entirely bailed out by $3.3 million in non-operating equity income from its GreenWave joint venture. Production volumes remain stubbornly stable to down, leaving the company heavily reliant on the upcoming May 2026 launch of its Montauk Ag Renewables project and its newly secured $200 million credit facility to hit full-year targets.
🐂 Bull Case
The highly anticipated Montauk Ag Renewables project in North Carolina is finally commissioned. Revenue generation commences in May 2026, providing a critical catalyst for H2 REG segment growth.
The EPA finalized 2026 and 2027 RFS standards with a partial waiver for 2025. Crucially, cellulosic volumes for 26/27 were bumped up to 1.36B and 1.43B D3 RINs, removing a massive overhang and supporting long-term RIN demand.
🐻 Bear Case
Operating profit is reversing. A $4.2 million surge in expenses related to dispensing RNG in exclusive pathways and GreenWave RIN distribution costs completely wiped out the benefit of higher top-line sales.
RNG production was dead flat at 1.4 million MMBtu, while REG production declined to 43 thousand MWh. The company is extracting more cash from trading RINs, not from increasing its actual biogas output.
⚖️ Verdict: ⚪
Neutral. The long-term macro picture is clearing up and the GreenWave JV is bearing fruit, but the core landfill gas operations are suffering from expense bloat and volume stagnation. Execution on the North Carolina Ag project is now paramount.
Key Themes
Operating Profit is Reversing Due to Dispensing Costs
Despite a positive narrative around top-line growth, operating margins are reversing. Q1 operating loss of $1.6M was driven by $4.2M in new expenses related to the cost of RINs distributed from GreenWave and proprietary pathway dispensing costs. While the GreenWave JV is contributing below the operating line, the sheer cost of routing this gas is severely compressing core operating margins.
Commodity Revenue Collapse
RNG volumes sold under fixed/floor-price contracts dropped by an alarming 82.1% YoY due to the expiration of fixed-price pathway contracts. Consequently, RNG commodity revenue plunged 49.3%. Montauk is increasingly naked to spot RIN pricing volatility as its fixed-price safety net shrinks.
Stagnant Production vs Implied Guidance Run-Rate
RNG production is stable but uninspiring at 1.4 million MMBtu (flat YoY). To hit the midpoint of FY26 guidance (5.9M MMBtu), the company needs to average 1.5M MMBtu per quarter going forward. The REG segment is actively decelerating, with production down from 46k to 43k MWh YoY due to the decommissioning of a Pico facility engine.
GreenWave JV Providing Financial Lifeline
The strategic pivot to bypass transportation constraints via the GreenWave Energy Partners JV is working. It generated a $3.3 million equity investment gain in Q1. This off-balance-sheet capacity matching is the sole reason Montauk posted a positive net income this quarter.
Montauk Ag Renewables Project Crossing the Finish Line
The massive North Carolina swine waste-to-energy project is finally commissioned. With production and revenue commencing in May 2026, this will be the primary driver for the expected H2 acceleration in the Renewable Electricity Generation (REG) segment.
EPA Finalizes Supportive Macro Backdrop
After quarters of crippling uncertainty, the EPA finalized the RFS standards, increasing the 2026 and 2027 cellulosic biofuel volume requirements to 1.36 billion and 1.43 billion D3 RINs respectively. This removes the severe regulatory overhang that previously crushed RIN prices and provides a stable demand foundation.
Balance Sheet De-Risked for Growth
The execution of a new $200 million senior credit facility with HASI in March 2026 secures capital access through 2031. By refinancing existing debt and leaving $45 million available, Montauk avoids near-term liquidity crunches as it ramps up its heavy CAPEX pipeline.
Other KPIs
Accelerating. Up 22.8% YoY from $8.8 million in 25Q1. The growth here starkly contrasts with the GAAP operating loss, highlighting how much of Montauk's current profitability relies on adding back non-cash impairments, debt extinguishment costs, and below-the-line equity income from GreenWave.
Accelerating costs. Up 33.8% YoY, primarily driven by $0.8 million in non-capitalizable costs dragging on the bottom line as the Montauk Ag Renewables project prepares for its May launch.
Guidance
Stable outlook. To hit the $182.5 million midpoint, Montauk must average ~$45.4 million in RNG revenue per quarter. With Q1 total revenue at $46.4M (including REG), the company is roughly on track, but highly dependent on the EPA's recent RFS rulings maintaining high RIN pricing.
Decelerating expectation. Management explicitly reduced the REG revenue outlook due to updated expectations on the exact timing of revenue commencement at the Montauk Ag Renewables facility (now slated for May 2026). Still implies significant absolute growth from previous years once online.
Stable outlook. With exactly 1.4 million MMBtu printed in Q1, Montauk is operating at a 5.6 million annualized run-rate. The company will require an acceleration in production volumes in the back half of the year to hit the 5.9 million midpoint.
Key Questions
GreenWave Dispensing Expenses
You recorded $4.2 million in expenses for GreenWave RIN distribution and proprietary pathway dispensing. Should we view this as a structural, recurring margin drag going forward, or are there economies of scale as volumes increase?
RNG Production Gap
Q1 RNG production was flat at 1.4 million MMBtu, implying a 5.6 million annual run rate. What specific facility enhancements or feedstock improvements give you confidence in accelerating production to hit your 5.8-6.0 million MMBtu guidance?
Fixed Contract Expirations
With RNG commodity revenue dropping 49% due to the expiration of fixed-price pathway contracts, what is your strategy for re-contracting? Are you comfortable remaining highly exposed to spot market RIN volatility?